ArticleFrontiers in public health2026
Risk stratification and determinant identification of high-need, high-cost ICU patients using machine learning: a large-scale retrospective study from a multi-specialty ICU in a tertiary hospital.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-magnification inpatient cases under DIP payment reform: prevalence, cost burden, and risk factors in an NHC-administered hospital in China.Frontiers in public health · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intensive care units (ICU) account for a disproportionate share of hospital costs. Retrospectively identifying high-need, high-cost (HNHC) ICU patients using machine learning (ML) may inform structured cost auditing and more efficient healthcare resource allocation. Methods: This retrospective study included adult patients with ICU admission (≥24 h) from multiple specialty ICUs in a Chinese tertiary hospital (2018-2024). HNHC patients were defined as the top 5% of annual ICU costs. Clinical, laboratory, and resource-use variables were extracted and preprocessed. Six ML models were developed using feature selection, class balancing, cross-validation, and Bayesian optimization, with performance evaluated by area under the receiver operating characteristic curve (AUC) and related metrics. Shapley Additive Explanations (SHAP) was applied for model interpretability. Results: Among 51,056 ICU patients, 2,556 (5.0%) were classified as HNHC. HNHC patients had longer ICU stays, greater disease complexity, and substantially higher use and duration of intensive therapies, resulting in markedly increased total and ICU-related costs. After correlation and Boruta feature selection, 19 variables were retained for model development. Among six ML models, the random forest (RF) achieved the highest discriminative performance in the independent test set, with an AUC of 0.942 (95% CI 0.931-0.952), followed by Extra Trees and LightGBM. The random forest model showed a favorable balance between sensitivity and F1 score in this highly imbalanced population. Decision curve analysis demonstrated stable net benefit across clinically relevant threshold probabilities. SHAP interpretation identified ICU length of stay and mechanical ventilation duration as the strongest contributors, revealing pronounced nonlinear effects, while diagnosis-related group (DRG) reform did not substantially alter the contribution patterns of key features. Stratified analyses confirmed that model performance and feature contribution patterns remained stable across the pre- and post-DRG reform periods. Conclusion: High ICU costs were primarily associated with intensive resource use rather than demographics alone. A RF model reliably classified HNHC patients and remained stable across DRG reform, supporting its use as a tool for retrospective risk stratification, identification of cost drivers, and more efficient allocation of critical care resources.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.